SABCS: Chest Wall Irradiation Does Not Impact Survival in Breast Cancer
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 16, 2024 -- For patients with intermediate-risk breast cancer, chest wall irradiation (CWI) after mastectomy does not influence 10-year overall survival, according to a study presented at the annual San Antonio Breast Cancer Symposium, held from Dec. 10 to 13 in San Antonio.
Ian Kunkler, M.B., B.Chir., from the University of Edinburgh in the United Kingdom, and colleagues examined the impact of adjuvant CWI following mastectomy and axillary surgical staging with operable breast cancer at intermediate-risk of locoregional recurrence. Data were included for 1,607 patients: 808 were randomly assigned to receive CWI after mastectomy and 799 were randomly assigned to no CWI after mastectomy; all participants received guideline-concordant axillary node clearance and systemic treatments.
The researchers found that CWI had no impact on overall survival at 10 years and had no impact on overall survival in node-negative (pN0) patients versus those with one to three positive axillary lymph nodes (pN1). Twenty-nine chest wall recurrences occurred, with chest wall recurrence-free survival probabilities of 98.8 and 97.1 percent for the CWI and no-CWI groups, respectively, at a median follow-up of 9.6 years. Chest wall recurrence was slightly reduced with CWI (hazard ratio, 0.45). No evidence of a significant differential treatment effect was seen for the pN1 and pN0 groups.
"This study demonstrates that CWI after a mastectomy has no influence on 10-year overall survival for patients with intermediate-risk breast cancer," Kunkler said in a statement. "The results are important considerations for shared decision-making conversations between patients and clinicians, as many patients eligible for postmastectomy CWI may not require the treatment."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-17 06:00
Read more
- FDA Approves Simplified Dosing Regimen for Acetadote (N-acetylcysteine for injection)
- Surgeon General Says U.S. Smoking Rates Have Tumbled, But Not for Everyone
- Cassava Sciences Topline Phase 3 Data for Simufilam Did Not Meet Co-Primary Endpoints
- Texas Sues NY Doctor for Prescribing Abortion Pill by Telehealth
- Climate Change Is Pushing More People to Get X-rays, CT Scans
- Current Prenatal Multivitamin, Mineral Labels Are Misleading
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions